医药行业分析
- (2021-09-14)
- (2021-09-14)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-13)
- (2021-09-10)
- (2021-09-10)
- (2021-09-10)
- (2021-09-10)
- (2021-09-10)
- (2021-09-10)
- (2021-09-10)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-09)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-08)
- (2021-09-07)
- (2021-09-07)
NeuExcell Therapeutics 和 Spark Therapeutics 发布杀青研讨单干协定,为亨廷顿跳舞症开辟新型基因疗法
(2021-09-07)- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)
- (2021-09-07)